MobiChina - A Prospective Multicenter Cohort Study

June 3, 2020 updated by: AO Innovation Translation Center

A Prospective Multicenter Cohort Study to Evaluate the Effect of Early Mobilization of Patients After Hip Fracture Fixation on Functional Outcomes in the Chinese Population

The study will assess the difference in functionality between early vs. standard mobilization after hip fracture in the Chinese population.

Study Overview

Status

Completed

Detailed Description

The primary objective of this prospective observational cohort study is to assess the difference in functionality between Group I and II (see mobilization regimens for the two groups above) at 6 weeks using the modified Barthel Index in the Chinese population.

The allocation of patients to the two groups will be performed on a clinic level: 50% of patients will be recruited by study sites in Group I (early mobilization). The other 50% of patients will be recruited by study sites in Group II. The sites are carefully selected after evaluating their standard procedures of mobilizing elderly patients after hip fractures. This process is documented using formal site selection questionnaires.

The modified Barthel Index is estimated at 75 points for Group II and at 85 points for Group I.

Patients aged 65 years and older with unstable intertrochanteric fractures (AO 31 A2 or A3) treated with an intramedullary nail will be included in this study.

The study visits will be defined as preoperative, surgery, discharge, 6 (± 2) weeks and 12 (± 2) weeks follow-up (FU) visits. Furthermore, there will be a telephone contact 12 months (± 1 month) postsurgery.

Study Type

Observational

Enrollment (Actual)

284

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • DCN Hospital
      • Chengdu, China
        • West China Hospital of Sichuan University
      • Kunming, China
        • Yunnan Second People Hospital
      • Nantong, China
        • Nantong University 1st Affiliated Hospital
      • Shanghai, China
        • Shanghai Sixth People Hospital
      • Shenzhen, China
        • The University of Hong Kong-Shenzhen Hospital
      • Xi'an, China
        • Hong Hui Hospital
    • Beijing
      • Beijing, Beijing, China
        • JiShuiTan Hopsital
    • Hebei
      • Hebei, Hebei, China
        • 3th Hospital of Hebei Medical University of Hebei
      • Hong Kong, Hong Kong
        • Queen Elisabeth Hospital
    • Pokfulam
      • Hong Kong, Pokfulam, Hong Kong
        • Queen Mary Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary care clinic

Description

Inclusion Criteria:

  • Age 65 and older
  • Diagnosis of an unstable intertrochanteric fractures (AO 31- A2 or A3) treated with an intramedullary nail
  • Ability to walk independently or with a walking aid prior to injury
  • Informed consent obtained, i.e.: Ability of the patient to understand the content of the patient information / Informed Consent Form and signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved written informed consent

Exclusion Criteria:

  • Severe dementia
  • Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Group I

Study sites in which patients perform early mobilization as per local standard of care, which is as follows:

  • 2 days (at the latest) after surgery: Transfer from the bed to a sitting chair for the first time
  • 4 (± 2) days after surgery: Stand up and put both feet on the ground for the first time (walking aids allowed)
  • 5 (± 2) days after surgery: Walking (at least partial weight bearing, walking aids allowed)
  • The patients are instructed by the investigator at the hospital about a standardized mobilization program to be followed at home
Group II
Study sites in which patients start walking (i.e. partial weight bearing, walking aids allowed) more than 7 days after surgery as per local standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Barthel Index
Time Frame: 6 weeks postoperative
Investigator completed score
6 weeks postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Barthel Index
Time Frame: Baseline
Modified Barthel Index is retrospectively assessed for the pre-injury status using an investigator completed score
Baseline
Modified Barthel Index
Time Frame: 12 weeks postoperative
Investigator completed score
12 weeks postoperative
Immobilization-related adverse events
Time Frame: From surgery to 1 year follow-up

Immobilization-related adverse events:

  • Pneumonia
  • Lung embolism
  • Pressure sores/ulcers
  • Urinary tract infections
From surgery to 1 year follow-up
Fixation failures
Time Frame: From surgery up to 1 year follow-up
As assessed by the local investigator
From surgery up to 1 year follow-up
Any other adverse events
Time Frame: From surgery up to 1 year follow-up
From surgery up to 1 year follow-up
Mortality
Time Frame: From surgery up to 1 year postoperative
From surgery up to 1 year postoperative
Muscle loss
Time Frame: From surgery up to 1 year follow-up
Calf circumference measurement comparison: Loss calculated in %
From surgery up to 1 year follow-up
Time to achieve partial and full weight bearing
Time Frame: From surgery to 1 year follow-up
Will be assessed during the patient interview
From surgery to 1 year follow-up
Duration of hospital stay
Time Frame: For the duration of hospital stay, an expected average of 3 weeks
For the duration of hospital stay, an expected average of 3 weeks
Numbers of re-admissions to the hospital
Time Frame: From surgery to 1 year follow-up
From surgery to 1 year follow-up
Quality of life: EuroQoL (EQ-5D)
Time Frame: 12 weeks postoperative
Quality of life questionnaire using the EQ-5D
12 weeks postoperative
Residential status
Time Frame: Baseline to 1 year follow-up
Will be assessed during the patient interview
Baseline to 1 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frankie Leung, MD, Queen Mary Hospital, Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

November 1, 2019

Study Registration Dates

First Submitted

November 14, 2014

First Submitted That Met QC Criteria

November 18, 2014

First Posted (Estimate)

November 20, 2014

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 3, 2020

Last Verified

September 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fracture

Subscribe